Clinical Trial Update: Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating irinotecan and temozolomide in combination with high-dose alkylator chemotherapy for newly diagnosed Ewing sarcoma; current st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma

Drugs mentioned

• Irinotecan (CPT-11) (Irinotecan)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Newly Diagnosed Ewing Sarcoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING